vs
MADRIGAL PHARMACEUTICALS, INC.（MDGL）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是LiveRamp Holdings, Inc.的1.5倍（$321.1M vs $212.2M），LiveRamp Holdings, Inc.净利率更高（18.8% vs -18.2%，领先37.0%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 8.6%）
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
MDGL vs RAMP — 直观对比
营收规模更大
MDGL
是对方的1.5倍
$212.2M
营收增速更快
MDGL
高出202.2%
8.6%
净利率更高
RAMP
高出37.0%
-18.2%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $321.1M | $212.2M |
| 净利润 | $-58.6M | $39.9M |
| 毛利率 | — | 71.9% |
| 营业利润率 | -18.6% | 18.6% |
| 净利率 | -18.2% | 18.8% |
| 营收同比 | 210.8% | 8.6% |
| 净利润同比 | 1.4% | 255.7% |
| 每股收益（稀释后） | $-2.55 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDGLRAMP
| Q4 25 | $321.1M | $212.2M | ||
| Q3 25 | $287.3M | $199.8M | ||
| Q2 25 | $212.8M | $194.8M | ||
| Q1 25 | $137.3M | $188.7M | ||
| Q4 24 | $103.3M | $195.4M | ||
| Q3 24 | $62.2M | $185.5M | ||
| Q2 24 | — | $176.0M | ||
| Q1 24 | $0 | $171.9M |
净利润MDGLRAMP
| Q4 25 | $-58.6M | $39.9M | ||
| Q3 25 | $-114.2M | $27.4M | ||
| Q2 25 | $-42.3M | $7.7M | ||
| Q1 25 | $-73.2M | $-6.3M | ||
| Q4 24 | $-59.4M | $11.2M | ||
| Q3 24 | $-107.0M | $1.7M | ||
| Q2 24 | — | $-7.5M | ||
| Q1 24 | $-147.5M | $-5.4M |
毛利率MDGLRAMP
| Q4 25 | — | 71.9% | ||
| Q3 25 | — | 70.2% | ||
| Q2 25 | — | 70.1% | ||
| Q1 25 | 96.7% | 69.3% | ||
| Q4 24 | — | 71.9% | ||
| Q3 24 | — | 72.4% | ||
| Q2 24 | — | 70.6% | ||
| Q1 24 | — | 72.2% |
营业利润率MDGLRAMP
| Q4 25 | -18.6% | 18.6% | ||
| Q3 25 | -39.7% | 10.7% | ||
| Q2 25 | -22.2% | 3.7% | ||
| Q1 25 | -57.8% | -6.1% | ||
| Q4 24 | -64.8% | 7.5% | ||
| Q3 24 | -187.1% | 4.0% | ||
| Q2 24 | — | -3.0% | ||
| Q1 24 | — | -8.3% |
净利率MDGLRAMP
| Q4 25 | -18.2% | 18.8% | ||
| Q3 25 | -39.8% | 13.7% | ||
| Q2 25 | -19.9% | 4.0% | ||
| Q1 25 | -53.4% | -3.3% | ||
| Q4 24 | -57.5% | 5.7% | ||
| Q3 24 | -172.0% | 0.9% | ||
| Q2 24 | — | -4.3% | ||
| Q1 24 | — | -3.1% |
每股收益（稀释后）MDGLRAMP
| Q4 25 | $-2.55 | $0.62 | ||
| Q3 25 | $-5.08 | $0.42 | ||
| Q2 25 | $-1.90 | $0.12 | ||
| Q1 25 | $-3.32 | $-0.10 | ||
| Q4 24 | $-2.50 | $0.17 | ||
| Q3 24 | $-4.92 | $0.03 | ||
| Q2 24 | — | $-0.11 | ||
| Q1 24 | $-7.38 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.7M | $403.4M |
| 总债务越低越好 | $339.9M | — |
| 股东权益账面价值 | $602.7M | $962.3M |
| 总资产 | $1.3B | $1.3B |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势，按日历期对齐
现金及短期投资MDGLRAMP
| Q4 25 | $198.7M | $403.4M | ||
| Q3 25 | $295.7M | $376.9M | ||
| Q2 25 | $186.2M | $371.1M | ||
| Q1 25 | $183.6M | $420.8M | ||
| Q4 24 | $100.0M | $384.3M | ||
| Q3 24 | $232.7M | $348.4M | ||
| Q2 24 | — | $342.7M | ||
| Q1 24 | $622.5M | $368.9M |
总债务MDGLRAMP
| Q4 25 | $339.9M | — | ||
| Q3 25 | $339.8M | — | ||
| Q2 25 | $118.4M | — | ||
| Q1 25 | $118.0M | — | ||
| Q4 24 | $117.6M | — | ||
| Q3 24 | $117.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $116.1M | — |
股东权益MDGLRAMP
| Q4 25 | $602.7M | $962.3M | ||
| Q3 25 | $625.7M | $943.8M | ||
| Q2 25 | $696.0M | $947.8M | ||
| Q1 25 | $710.6M | $948.9M | ||
| Q4 24 | $754.4M | $957.7M | ||
| Q3 24 | $777.2M | $932.1M | ||
| Q2 24 | — | $951.9M | ||
| Q1 24 | $850.8M | $949.1M |
总资产MDGLRAMP
| Q4 25 | $1.3B | $1.3B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.0B | $1.2B | ||
| Q1 25 | $996.6M | $1.3B | ||
| Q4 24 | $1.0B | $1.3B | ||
| Q3 24 | $1.1B | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | $1.1B | $1.2B |
负债/权益比MDGLRAMP
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.17× | — | ||
| Q4 24 | 0.16× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-133.5M | — |
| 自由现金流经营现金流 - 资本支出 | $-133.8M | — |
| 自由现金流率自由现金流/营收 | -41.7% | — |
| 资本支出强度资本支出/营收 | 0.1% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDGLRAMP
| Q4 25 | $-133.5M | — | ||
| Q3 25 | $79.8M | $57.4M | ||
| Q2 25 | $-47.1M | $-15.8M | ||
| Q1 25 | $-88.9M | — | ||
| Q4 24 | $-104.5M | $45.1M | ||
| Q3 24 | $-67.0M | $55.6M | ||
| Q2 24 | — | $-9.3M | ||
| Q1 24 | $-149.2M | — |
自由现金流MDGLRAMP
| Q4 25 | $-133.8M | — | ||
| Q3 25 | $79.0M | $56.8M | ||
| Q2 25 | — | $-16.2M | ||
| Q1 25 | — | — | ||
| Q4 24 | $-104.7M | $44.8M | ||
| Q3 24 | $-67.8M | $55.4M | ||
| Q2 24 | — | $-9.6M | ||
| Q1 24 | $-149.5M | — |
自由现金流率MDGLRAMP
| Q4 25 | -41.7% | — | ||
| Q3 25 | 27.5% | 28.4% | ||
| Q2 25 | — | -8.3% | ||
| Q1 25 | — | — | ||
| Q4 24 | -101.3% | 22.9% | ||
| Q3 24 | -109.0% | 29.8% | ||
| Q2 24 | — | -5.4% | ||
| Q1 24 | — | — |
资本支出强度MDGLRAMP
| Q4 25 | 0.1% | 0.1% | ||
| Q3 25 | 0.3% | 0.3% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | 0.2% | 0.1% | ||
| Q3 24 | 1.3% | 0.1% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 1.0% |
现金转化率MDGLRAMP
| Q4 25 | — | — | ||
| Q3 25 | — | 2.09× | ||
| Q2 25 | — | -2.04× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
RAMP
暂无分部数据
